Kobo Biotech Ltd

Kobo Biotech Ltd (KOBO) is a micro-cap Chemicals company valued at ₹10 crore operating in Commodity Chemicals on the NSE and BSE.

Recent price move

Kobo Biotech Ltd last traded at ₹4.27, modestly down 1.84% on the day.

Financial performance

The company's business has not improved, with annual revenue remaining at ₹0 crore and annual net profit worsening to a ₹5 crore loss, matching the previous year's loss. The latest quarter shows a net loss of ₹1 crore, consistent with the same quarter a year earlier, indicating no improvement in profitability.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -0.08 times book value.

Things to watch

The company reported a net loss of ₹35 crore in its latest financial year, showing a widening loss over the past three years. The latest quarter also shows a net loss of ₹1 crore, with no change compared to the same quarter a year earlier, highlighting persistent financial weakness.

Where it stands

Kobo Biotech Ltd continues to report significant losses, with a net loss of ₹5 crore for the latest fiscal year and a net loss of ₹1 crore in the latest quarter. The most significant figure is the net loss of ₹35 crore in the latest financial year, reflecting ongoing challenges in the business.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.